Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

被引:7
|
作者
Ma, Xiao-Dong [1 ]
Zhang, Xuan [4 ,5 ]
Yang, Shi-Qiong [1 ]
Dai, Hui-Fang [3 ]
Yang, Liu-Meng [4 ]
Gu, Shuang-Xi [1 ]
Zheng, Yong-Tang [4 ]
He, Qiu-Qin [1 ]
Chen, Fen-Er [1 ,2 ]
机构
[1] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China
[2] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China
[3] Fudan Univ, Sch Pharm, Shanghai 200031, Peoples R China
[4] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China
[5] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
HIV; NNRTIs; Benzophenone derivatives; Benzhydrol; SAR; PROTEIN-BINDING SITES; MOLECULAR DOCKING; SEARCH; BENZOPHENONES; RESISTANCE; DISCOVERY; INFECTION; GW678248; NNRTIS;
D O I
10.1016/j.bmc.2011.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of (+/-)-benzhydrol derivatives featuring the essential sulfonamide group at the para position on the C-ring were synthesized and evaluated for the potential anti-HIV activity in C8166 cells. Most of these analogues demonstrated low concentration inhibitory activity with EC50 values less than 1 mu M against the wild-type HIV-1. In particular, compound 7h was identified as the highest active inhibitor of wildtype HIV-1 with an EC50 value of 0.12 mu M and selectivity index value of 312.73. Furthermore, some of them also exhibited moderate activity against the double mutant strain A(17) (K103N + Y181C) with EC50 values lower than 5 mu M. In addition, the binding modes with RT and the preliminary structure-activity relationships of these derivatives were also explored for further chemical modifications. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:4704 / 4709
页数:6
相关论文
共 50 条
  • [21] Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
    Kim, Junwon
    Lee, Doohyun
    Park, Changmin
    So, Wonyoung
    Jo, Mina
    Ok, Taedong
    Kwon, Jeongjin
    Kong, Sunju
    Jo, Suyeon
    Kim, Youngmi
    Choi, Jihyun
    Kim, Hyoung Cheul
    Ko, Yoonae
    Choi, Inhee
    Park, Youngsam
    Yoon, Jaewan
    Ju, Moon Kyeong
    Kim, Junghwan
    Han, Sung-Jun
    Kim, Tae-Hee
    Cechetto, Jonathan
    Nam, Jiyoun
    Sommer, Peter
    Liuzzi, Michel
    Lee, Jinhwa
    No, Zaesung
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (08): : 678 - 682
  • [22] Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
    Tian, Xingtao
    Qin, Bingjie
    Lu, Hong
    Lai, Weihong
    Jiang, Shibo
    Lee, Kuo-Hsiung
    Chen, Chin Ho
    Xie, Lan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (18) : 5482 - 5485
  • [23] Docking of non-nucleoside inhibitors: Neotripterifordin and its derivatives to HIV-1 reverse transcriptase
    Zhou, ZG
    Madrid, M
    Madura, JD
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2002, 49 (04) : 529 - 542
  • [24] Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability
    Cullen, Matthew D.
    De Clercq, Erik
    Pannecouque, Christophe
    Hartman, Tracy L.
    Buckheit, Robert W., Jr.
    Deng, Bo Liang
    Cushman, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 666 - 666
  • [25] Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors
    Ellis, David
    Kuhen, Kelli L.
    Anaclerio, Beth
    Wu, Baogen
    Wolff, Karen
    Yin, Hong
    Bursulaya, Badry
    Caldwell, Jeremy
    Karanewsky, Donald
    He, Yun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4246 - 4251
  • [26] Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability
    Cullen, Matthew D.
    Deng, Bo-Liang
    Hartman, Tracy L.
    Watson, Karen M.
    Buckheit, Robert W., Jr.
    Pannecouque, Christophe
    De Clercq, Erik
    Cushman, Mark
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (20) : 4854 - 4867
  • [27] Mechanisms of resistance of HIV-1 reverse transcriptase to nucleoside and non-nucleoside inhibitors
    Boyer, PL
    Tantillo, C
    Ding, J
    Ferris, AL
    Clark, P
    Arnold, E
    Hughes, SH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 6 - 6
  • [28] Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
    Alexandre, Francois-Rene
    Amador, Agnes
    Bot, Stephanie
    Caillet, Catherine
    Convard, Thierry
    Jakubik, Jocelyn
    Musiu, Chiara
    Poddesu, Barbara
    Vargiu, Luana
    Liuzzi, Michel
    Roland, Arlene
    Seifer, Maria
    Standring, David
    Storer, Richard
    Dousson, Cyril B.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 392 - 395
  • [29] Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase
    De La Rosa, Martha
    Kim, Hong Woo
    Gunic, Esmir
    Jenket, Cheryl
    Boyle, Uyen
    Koh, Yung-hyo
    Korboukh, Ilia
    Allan, Matthew
    Zhang, Weijian
    Chen, Huanming
    Xu, Wen
    Nilar, Shahul
    Yao, Nanhua
    Hamatake, Robert
    Lang, Stanley A.
    Hong, Zhi
    Zhang, Zhijun
    Girardet, Jean-Luc
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4444 - 4449
  • [30] Recent Advances in the DABOs Family as Potent HIV-1 non-Nucleoside Reverse Transcriptase Inhibitors
    Yu, Mingyan
    Fan, Erkang
    Wu, Jingde
    Liu, Xinyong
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (16) : 2376 - 2385